Soleno Therapeutics (6XC.F) Q2 2025 Earnings

7MayConfirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-1.68
-1.29
-0.91
-0.52

Details

Expected EPS
-0.8576448999999999
Actual EPS
-0.8399614999999999
Surprise EPS
0.02
Surprise Percent
+2.06%

Description

Soleno Therapeutics (6XC.F) has reported earnings of -0.8399614999999999 per share for Q2 2025.

0 Comments

Share your thoughts